Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma.
Zangari, Maurizio; Esseltine, Dixie; Lee, Choon-Kee; Barlogie, Bart; Elice, Francesca; Burns, Michael J.; Kang, Seung-Hee; Yaccoby, Shmuel; Najarian, Kevin; Richardson, Paul; Sonneveld, Peter; Tricot, Guido; British Journal of Haematology, 2005, vol. 131, issue 1, p 71, ISSN 00071048. ISBN 00071048.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef